38
total announcements
SYNGENE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 14 Oct 2026
Market Cap
₹15,255 Cr
P/E (TTM)
69.1
P/E (Forward)
35.4
EPS (TTM)
₹5.49
52W Low
₹344.45
52W High
₹678.95
Dividend Yield
0.34%
Beta
0.07
Price / Book
3.2
Debt / Equity
9.5
Revenue (TTM)
₹3,600 Cr
Gross Margin
68.00%
Operating Margin
3.90%
Syngene International Limited
Syngene International Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of securities and listing on stock exchanges.
Syngene International Limited
Syngene International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Syngene International Limited
Syngene International Limited has cancelled a meeting with Bajaj AMC scheduled for September 24, 2026.
Syngene International Limited
Syngene International Limited has informed the Exchange about Resignation of Director/KMP/SMP
Syngene International Limited
Syngene International Limited has informed the Exchange regarding the resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the company w.e.f. close of business hours of September 21, 2026.
Syngene International Limited
Syngene International Limited has informed the Exchange about a scheduled meeting with analysts/institutional investors on September 24, 2026, in Bengaluru. The meeting will be held online at 12:00 PM IST. The company will not disclose any unpublished price-sensitive information during the meeting.
Syngene International Limited
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors on September 17, 2026, at 09:00 AM in Mumbai.
Syngene International Limited
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors, to be held on September 17, 2026, in Bengaluru.
Syngene International Limited
Syngene International Limited has informed the Exchange about the Communication regarding remittance of final dividend for the FY 2025-26.
Syngene International Limited
Syngene International Limited has granted 14,26,061 Performance Share Units under its Long Term Incentive Performance Share Plan 2023 to eligible employees.
Syngene International Limited
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors, to be held on August 31, 2026, and September 1, 2026, in Hong Kong. The company will not disclose any unpublished price sensitive information during the meeting.
Syngene International Limited
Syngene International Limited has informed the Exchange about Acquisition of AMPIN C&I Power Twelve Private Limited for the purpose of acquisition of renewable power. The acquisition aligns with the Company’s renewable energy objectives, supporting the procurement of green energy and advancing its decarbonization goals.
Syngene International Limited
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors, to be held virtually on August 28, 2026. The meeting timings are 12:00 PM IST. The company will not disclose any unpublished price sensitive information during the meeting.
Syngene International Limited
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors, to be held on August 13 and 14, 2026, in Mumbai. The meeting is organized by Emkay Global, and the company will not disclose any unpublished price sensitive information (UPSI) during the meeting.
Syngene International Limited
Syngene International Limited has informed the Exchange about the transcript of the Q1 FY2027 Earnings Conference call held on July 30, 2026, which is uploaded on the Company’s website.
Syngene International Limited
Syngene International Limited has submitted the Exchange a copy Scrutinizer's report of Annual General Meeting held on July 29, 2026. Further, the company has informed the Exchange regarding voting results.
Syngene International Limited
Syngene International Limited has informed the Exchange about the link of the recording of its Q1 FY27 post-earnings call, which was conducted on July 30, 2026, and is available on the company's website.
Syngene International Limited
Syngene International Limited has informed the Exchange about the publication of their financial results for the quarter ended June 30, 2026, in the Financial Express (All India Edition) and Vijayavani (Bengaluru Edition) newspapers.
Syngene International Limited
Syngene International Limited has released an investor presentation for the quarter ended June 30, 2026, highlighting its Q1 FY27 performance, including revenue from operations of Rs 736 Cr (-16% Y-o-Y), operating EBITDA margin of 12%, and PAT of Rs 1 Cr. The company has also signed a Memorandum of Understanding with BRIC-Translational Health Science and Technology Institute (THSTI) for a joint operational partnership for early and late-phase clinical development, translational research, and bioanalytical sciences.
Syngene International Limited
Syngene International Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 29, 2026. The meeting was held through video conferencing and 117 members were present. The company adopted audited financial statements and declared a final dividend of Rs. 1.25 per equity share.